Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 793,678 | 633,677 | 569,299 | 559,390 | 527,198 |
| Marketable Securities | 327,694 | 761,847 | 895,777 | 831,808 | 493,602 |
| Receivables | 173,838 | 75,964 | 85,517 | 143,250 | 183,135 |
| Inventories | 57,207 | 30,848 | 14,147 | 30,464 | 112,430 |
| TOTAL | $1,407,153 | $1,546,511 | $1,588,576 | $1,589,585 | $1,331,254 |
| Non-Current Assets | |||||
| PPE Net | 697,715 | 715,812 | 696,911 | 433,609 | 133,176 |
| Intangibles | 334,724 | 68,915 | 30,992 | 694,492 | 694,492 |
| Other Non-Current Assets | 58,995 | 3,441 | 2,562 | 41,602 | 45,358 |
| TOTAL | $1,091,434 | $788,168 | $730,465 | $1,169,703 | $873,026 |
| Total Assets | $2,498,587 | $2,334,679 | $2,319,041 | $2,759,288 | $2,204,280 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 71,296 | 14,206 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 74,942 | 71,194 | 49,327 | 101,292 | 74,642 |
| Accrued Expenses | 313,714 | 242,783 | 285,363 | 269,642 | 248,119 |
| Other current liabilities | 14,374 | 4,797 | 24,736 | 19,702 | 12,475 |
| TOTAL | $506,167 | $368,254 | $397,829 | $432,624 | $392,348 |
| Non-Current Liabilities | |||||
| Long Term Debt | 223,863 | 280,569 | 0 | N/A | N/A |
| Deferred Revenues | 16,296 | 17,468 | 21,510 | 27,566 | 45,037 |
| Other Non-Current Liabilities | 71,089 | 38,645 | 268,179 | 415,105 | 454,099 |
| TOTAL | $898,792 | $870,242 | $564,807 | $1,130,812 | $883,456 |
| Total Liabilities | $1,404,959 | $1,238,496 | $962,636 | $1,563,436 | $1,275,804 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 246,392 | 242,089 | 235,772 | 218,189 | 210,336 |
| Common Shares | 2,427 | 2,385 | 2,320 | 2,149 | 2,072 |
| Retained earnings | -5,261,784 | -4,705,450 | -3,966,895 | -3,521,867 | -3,414,835 |
| Other shareholders' equity | 155,485 | 22,094 | -306 | 196,122 | 140,580 |
| TOTAL | $1,093,628 | $1,096,183 | $1,356,405 | $1,195,852 | $928,476 |
| Total Liabilities And Equity | $2,498,587 | $2,334,679 | $2,319,041 | $2,759,288 | $2,204,280 |